Lee Jung-Soo, Kim Moon-Key, Kang Sang-Hoon
Department of Oral and Maxillofacial Surgery, National Health Insurance Service Ilsan Hospital, Goyang, Korea.
J Korean Assoc Oral Maxillofac Surg. 2020 Aug 31;46(4):228-234. doi: 10.5125/jkaoms.2020.46.4.228.
The number of patients undergoing oral anticoagulant therapy for cardiovascular and cerebrovascular disease is increasing. However, the risk of bleeding after tooth extraction in patients receiving warfarin is unclear. Here, we assess the risk of bleeding after tooth extraction in patients on warfarin.
The study included 260 patients taking warfarin who underwent tooth extraction (694 teeth). The patients were divided into those whose teeth were extracted while they were taking warfarin, those who discontinued warfarin before extraction, and those who underwent extraction while receiving heparin bridging therapy. Bleeding complications in the two groups were compared.
Of the 260 patients, 156 underwent extraction while taking warfarin, 70 stopped taking warfarin before extractions, and 34 received heparin bridging therapy and stopped taking either medication before extractions. Bleeding complications occurred in 9 patients (3.5%) and 9 tooth sites (1.3%). Among the 9 patients with bleeding complications, 6 underwent extraction while taking warfarin, 2 stopped warfarin before extraction, and 1 underwent extraction after receiving heparin bridging therapy. No significant difference was seen between patient groups regarding bleeding after extractions (=0.917).
Warfarin use does not increase the risk of post-extraction bleeding and can therefore be continued during tooth extraction.
接受口服抗凝药治疗心血管和脑血管疾病的患者数量正在增加。然而,接受华法林治疗的患者拔牙后出血风险尚不清楚。在此,我们评估服用华法林的患者拔牙后出血风险。
该研究纳入了260例服用华法林且接受拔牙治疗的患者(共694颗牙齿)。患者被分为在服用华法林期间拔牙的患者、拔牙前停用华法林的患者以及在接受肝素桥接治疗时拔牙的患者。比较两组的出血并发症情况。
260例患者中,156例在服用华法林期间拔牙,70例在拔牙前停用华法林,34例接受肝素桥接治疗且在拔牙前停用两种药物中的任意一种。9例患者(3.5%)和9个牙位(1.3%)发生出血并发症。在9例有出血并发症的患者中,6例在服用华法林期间拔牙,2例在拔牙前停用华法林,1例在接受肝素桥接治疗后拔牙。拔牙后患者组间出血情况无显著差异(P = 0.917)。
使用华法林不会增加拔牙后出血风险,因此在拔牙期间可以继续使用。